Monday, October 18, 2021
News

Pfizer, Moderna best Covid booster for J&J recipients: US NIH

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Washington | Thursday, 2021 5:45:06 PM IST
People who have taken Johnson and Johnson's Covid vaccine will have better results with a booster shot of either Pfizer or Moderna, finds a study led by the US National Institutes of Health (NIH).

The NIH study on "mixing and matching" Covid vaccines included more than 450 adults who were divided into groups and received an extra shot of their original vaccine or a booster from a different company, the CNBC reported.

The participants had already taken either of the three vaccines currently available in the country: Pfizer, Moderna or J&J. Antibody levels were measured two weeks and four weeks after the boosters were given.

The results, which hasn't yet been peer-reviewed, showed that all the combinations boosted antibody levels higher, but Pfizer's and Moderna's boosters appeared to work best.

Booster dose of either the Moderna or Pfizer vaccines increased their antibody responses more often than those who received an extra dose of J&J, the report said.

The study showed recipients of Moderna or Pfizer's original vaccines could easily swap third doses; the results were about the same. Volunteers who originally received the J&J vaccine appear to have gotten a better immune response if they got a booster made by Pfizer or Moderna.

There were no serious side effects tied to the additional shots and no new symptoms emerged after participants received the booster shots, researchers said. Two participants vomited after their boosters; one had received Moderna and the other J&J. Two other people who got a J&J booster reported fatigue or insomnia.

"These data suggest that if a vaccine is approved or authorised as a booster, an immune response will be generated regardless of the primary Covid-19 vaccination regimen," researchers wrote in the study.

"Heterologous prime boost strategies may offer immunological advantages to optimise the breadth and longevity of protection achieved with currently available vaccines," they added.

J&J's one-dose vaccine uses an adenovirus, while Pfizer's and Moderna's two-dose vaccines use mRNA technology. Scientists believe that by "mixing and matching" vaccines that use different platforms, people may be able to get broader protection against the coronavirus and its new variants.

--IANS rvt/skp/

( 368 Words)

2021-10-14-11:58:02 (IANS)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
Ranking healthfulness of foods from firs...
Slip disc, sciatica can be treated with ...
Dasara beats Covid fears, boosts tourism...
Statins may reduce risk of death from Co...
Contraceptive pill can reduce diabetes r...
India adds 14,146 new Covid cases, over ...
More...
 
INDIA WORLD ASIA
Abrogation of Article 370 paved path for...
Centre will provide all possible help to...
G-23 not separate group, Congress high c...
Eyeing 2023 polls, tribal parties revive...
Army column arrives in Wayanad for rescu...
Kerala Rain: IMD issues 'Yellow alert' i...
More...    
 
 Top Stories
Chinese, Saudi Arabian FMs talk ove... 
Odisha Vigilance raids several plac... 
Will make you feel proud of me afte... 
Delhi Police arrests three for siph... 
Mandaviya lauds Uttarakhand govt fo... 
Health, agriculture, green growth a... 
Ensuring prosperity in life of ever... 
ICC T20 WC, Rd 1: Greaves' all-roun...